Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia

Fig. 3

The expression of NDRG2 and miRNAs before and after transfecting with miRNA inhibitors. The corresponding miRNAs fall significantly in groups treated with miR-28-5p and miR-650 inhibitors groups than treated with miR-NC (P = 0.009, a; P = 0.019, c), separately. The primary CLL cells express obviously increased NDRG2 mRNA in miR-28-5p (P = 0.001) (b) and miR-650 (P = 0.031) (d) inhibitors groups

Back to article page